China PEGylated Proteins Market Research Report 2018

February 2018 | 96 pages | ID: CC7A6B0626FEN
QYResearch

Abstracts

The global PEGylated Proteins market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the PEGylated Proteins development status and future trend in China, focuses on top players in China, also splits PEGylated Proteins by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• ENZON Pharmaceuticals
• Merck Sharp & Dohme
• Roche
• Pfizer
• Amgen
• UCB
• Crealta (Savient)

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Colony Stimulating Factors
• Interferons
• Erythropoietin (EPO)
• Recombinant Factor Viii
• Monoclonal Antibodies
• Others

On the basis of the end users/application, this report covers

• Cancer Treatment
• Hepatitis
• Chronic Kidney Disease
• Leukemia
• SCID
• Rheumatoid Arthritis & Crohn's Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China PEGylated Proteins Market Research Report 2017

1 PEGYLATED PROTEINS OVERVIEW

1.1 Product Overview and Scope of PEGylated Proteins
1.2 Classification of PEGylated Proteins by Product Category
  1.2.1 China PEGylated Proteins Sales (K MT) Comparison by Type (2012-2022)
  1.2.2 China PEGylated Proteins Sales (K MT) Market Share by Type in 2016
  1.2.3 Colony Stimulating Factors
  1.2.4 Interferons
  1.2.5 Erythropoietin (EPO)
  1.2.6 Recombinant Factor Viii
  1.2.7 Monoclonal Antibodies
  1.2.8 Others
1.3 China PEGylated Proteins Market by Application/End Users
  1.3.1 China PEGylated Proteins Sales (K MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Cancer Treatment
  1.3.3 Hepatitis
  1.3.4 Chronic Kidney Disease
  1.3.5 Leukemia
  1.3.6 SCID
  1.3.7 Rheumatoid Arthritis & Crohn's Disease
  1.3.8 Others
1.4 China PEGylated Proteins Market by Region
  1.4.1 China PEGylated Proteins Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China PEGylated Proteins Status and Prospect (2012-2022)
  1.4.3 East China PEGylated Proteins Status and Prospect (2012-2022)
  1.4.4 Southwest China PEGylated Proteins Status and Prospect (2012-2022)
  1.4.5 Northeast China PEGylated Proteins Status and Prospect (2012-2022)
  1.4.6 North China PEGylated Proteins Status and Prospect (2012-2022)
  1.4.7 Central China PEGylated Proteins Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of PEGylated Proteins (2012-2022)
  1.5.1 China PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2022)
  1.5.2 China PEGylated Proteins Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA PEGYLATED PROTEINS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China PEGylated Proteins Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China PEGylated Proteins Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China PEGylated Proteins Average Price (USD/MT) by Players/Manufacturers (2012-2017)
2.4 China PEGylated Proteins Market Competitive Situation and Trends
  2.4.1 China PEGylated Proteins Market Concentration Rate
  2.4.2 China PEGylated Proteins Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers PEGylated Proteins Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA PEGYLATED PROTEINS SALES AND REVENUE BY REGION (2012-2017)

3.1 China PEGylated Proteins Sales (K MT) and Market Share by Region (2012-2017)
3.2 China PEGylated Proteins Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China PEGylated Proteins Price (USD/MT) by Regions (2012-2017)

4 CHINA PEGYLATED PROTEINS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China PEGylated Proteins Sales (K MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China PEGylated Proteins Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China PEGylated Proteins Price (USD/MT) by Type (2012-2017)
4.4 China PEGylated Proteins Sales Growth Rate (%) by Type (2012-2017)

5 CHINA PEGYLATED PROTEINS SALES BY APPLICATION (2012-2017)

5.1 China PEGylated Proteins Sales (K MT) and Market Share by Application (2012-2017)
5.2 China PEGylated Proteins Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA PEGYLATED PROTEINS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 ENZON Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 PEGylated Proteins Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck Sharp & Dohme
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 PEGylated Proteins Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Sharp & Dohme PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 PEGylated Proteins Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 PEGylated Proteins Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 PEGylated Proteins Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 UCB
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 PEGylated Proteins Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 UCB PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Crealta (Savient)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 PEGylated Proteins Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Crealta (Savient) PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview

7 PEGYLATED PROTEINS MANUFACTURING COST ANALYSIS

7.1 PEGylated Proteins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of PEGylated Proteins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 PEGylated Proteins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of PEGylated Proteins Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA PEGYLATED PROTEINS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China PEGylated Proteins Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China PEGylated Proteins Sales (K MT) Forecast by Type (2017-2022)
11.3 China PEGylated Proteins Sales (K MT) Forecast by Application (2017-2022)
11.4 China PEGylated Proteins Sales (K MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table PEGylated Proteins Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table PEGylated Proteins Sales (K MT) by Application (2016-2022)
Figure Product Picture of PEGylated Proteins
Table China PEGylated Proteins Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China PEGylated Proteins Sales Volume Market Share by Types in 2016
Figure Colony Stimulating Factors Product Picture
Figure Interferons Product Picture
Figure Erythropoietin (EPO) Product Picture
Figure Recombinant Factor Viii Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Others Product Picture
Figure China PEGylated Proteins Sales (K MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of PEGylated Proteins by Application in 2016
Figure Cancer Treatment Examples
Table Key Downstream Customer in Cancer Treatment
Figure Hepatitis Examples
Table Key Downstream Customer in Hepatitis
Figure Chronic Kidney Disease Examples
Table Key Downstream Customer in Chronic Kidney Disease
Figure Leukemia Examples
Table Key Downstream Customer in Leukemia
Figure SCID Examples
Table Key Downstream Customer in SCID
Figure Rheumatoid Arthritis & Crohn's Disease Examples
Table Key Downstream Customer in Rheumatoid Arthritis & Crohn's Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2022)
Figure China PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2022)
Figure China PEGylated Proteins Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China PEGylated Proteins Sales of Key Players/Manufacturers (2012-2017)
Table China PEGylated Proteins Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China PEGylated Proteins Sales Share (%) by Players/Manufacturers
Figure 2017 China PEGylated Proteins Sales Share (%) by Players/Manufacturers
Table China PEGylated Proteins Revenue by Players/Manufacturers (2012-2017)
Table China PEGylated Proteins Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China PEGylated Proteins Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China PEGylated Proteins Revenue Market Share (%) by Players/Manufacturers
Table China Market PEGylated Proteins Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market PEGylated Proteins Average Price of Key Players/Manufacturers in 2016
Figure China PEGylated Proteins Market Share of Top 3 Players/Manufacturers
Figure China PEGylated Proteins Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers PEGylated Proteins Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers PEGylated Proteins Product Category
Table China PEGylated Proteins Sales (K MT) by Regions (2012-2017)
Table China PEGylated Proteins Sales Share (%) by Regions (2012-2017)
Figure China PEGylated Proteins Sales Share (%) by Regions (2012-2017)
Figure China PEGylated Proteins Sales Market Share (%) by Regions in 2016
Table China PEGylated Proteins Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China PEGylated Proteins Revenue Market Share (%) by Regions (2012-2017)
Figure China PEGylated Proteins Revenue Market Share (%) by Regions (2012-2017)
Figure China PEGylated Proteins Revenue Market Share (%) by Regions in 2016
Table China PEGylated Proteins Price (USD/MT) by Regions (2012-2017)
Table China PEGylated Proteins Sales (K MT) by Type (2012-2017)
Table China PEGylated Proteins Sales Share (%) by Type (2012-2017)
Figure China PEGylated Proteins Sales Share (%) by Type (2012-2017)
Figure China PEGylated Proteins Sales Market Share (%) by Type in 2016
Table China PEGylated Proteins Revenue (Million USD) and Market Share by Type (2012-2017)
Table China PEGylated Proteins Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of PEGylated Proteins by Type (2012-2017)
Figure Revenue Market Share of PEGylated Proteins by Type in 2016
Table China PEGylated Proteins Price (USD/MT) by Types (2012-2017)
Figure China PEGylated Proteins Sales Growth Rate (%) by Type (2012-2017)
Table China PEGylated Proteins Sales (K MT) by Applications (2012-2017)
Table China PEGylated Proteins Sales Market Share (%) by Applications (2012-2017)
Figure China PEGylated Proteins Sales Market Share (%) by Application (2012-2017)
Figure China PEGylated Proteins Sales Market Share (%) by Application in 2016
Table China PEGylated Proteins Sales Growth Rate (%) by Application (2012-2017)
Figure China PEGylated Proteins Sales Growth Rate (%) by Application (2012-2017)
Table ENZON Pharmaceuticals PEGylated Proteins Basic Information List
Table ENZON Pharmaceuticals PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure ENZON Pharmaceuticals PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure ENZON Pharmaceuticals PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure ENZON Pharmaceuticals PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Merck Sharp & Dohme PEGylated Proteins Basic Information List
Table Merck Sharp & Dohme PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Merck Sharp & Dohme PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Merck Sharp & Dohme PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure Merck Sharp & Dohme PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Roche PEGylated Proteins Basic Information List
Table Roche PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Roche PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Roche PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure Roche PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Pfizer PEGylated Proteins Basic Information List
Table Pfizer PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Pfizer PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Pfizer PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure Pfizer PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Amgen PEGylated Proteins Basic Information List
Table Amgen PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Amgen PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Amgen PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure Amgen PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table UCB PEGylated Proteins Basic Information List
Table UCB PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure UCB PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure UCB PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure UCB PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Crealta (Savient) PEGylated Proteins Basic Information List
Table Crealta (Savient) PEGylated Proteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Crealta (Savient) PEGylated Proteins Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Crealta (Savient) PEGylated Proteins Sales Market Share (%) in China (2012-2017)
Figure Crealta (Savient) PEGylated Proteins Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PEGylated Proteins
Figure Manufacturing Process Analysis of PEGylated Proteins
Figure PEGylated Proteins Industrial Chain Analysis
Table Raw Materials Sources of PEGylated Proteins Major Players/Manufacturers in 2016
Table Major Buyers of PEGylated Proteins
Table Distributors/Traders List
Figure China PEGylated Proteins Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure China PEGylated Proteins Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China PEGylated Proteins Price (USD/MT) Trend Forecast (2017-2022)
Table China PEGylated Proteins Sales (K MT) Forecast by Type (2017-2022)
Figure China PEGylated Proteins Sales (K MT) Forecast by Type (2017-2022)
Figure China PEGylated Proteins Sales Volume Market Share Forecast by Type in 2022
Table China PEGylated Proteins Sales (K MT) Forecast by Application (2017-2022)
Figure China PEGylated Proteins Sales Volume Market Share Forecast by Application (2017-2022)
Figure China PEGylated Proteins Sales Volume Market Share Forecast by Application in 2022
Table China PEGylated Proteins Sales (K MT) Forecast by Regions (2017-2022)
Table China PEGylated Proteins Sales Volume Share Forecast by Regions (2017-2022)
Figure China PEGylated Proteins Sales Volume Share Forecast by Regions (2017-2022)
Figure China PEGylated Proteins Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources